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Abstract 
Background: The use of malaria infection prevalence among febrile patients at clinics has a potential to be a valu-
able epidemiological surveillance tool. However, routine data are incomplete and not all fevers are tested. This study 
was designed to screen all fevers for malaria infection in Kenya to explore the epidemiology of fever test positivity 
rates.
Methods: Random sampling was used within five malaria epidemiological zones of Kenya (i.e., high lake endemic, 
moderate coast endemic, highland epidemic, seasonal low transmission and low risk zones). The selected sample was 
representative of the number of hospitals, health centres and dispensaries within each zone. Fifty patients with fever 
presenting to each sampled health facility during the short rainy season were screened for malaria infection using a 
rapid diagnostic test (RDT). Details of age, pregnancy status and basic demographics were recorded for each patient 
screened.
Results: 10,557 febrile patients presenting to out-patient clinics at 234 health facilities were screened for malaria 
infection. 1633 (15.5%) of the patients surveyed were RDT positive for malaria at 124 (53.0%) facilities. Infection preva-
lence among non-pregnant patients varied between malaria risk zones, ranging from 0.6% in the low risk zone to 
41.6% in the high lake endemic zone. Test positivity rates (TPR) by age group reflected the differences in the intensity 
of transmission between epidemiological zones. In the lake endemic zone, 6% of all infections were among children 
aged less than 1 year, compared to 3% in the coast endemic, 1% in the highland epidemic zone, less than 1% in the 
seasonal low transmission zone and 0% in the low risk zone. Test positivity rate was 31% among febrile pregnant 
women in the high lake endemic zone compared to 9% in the coast endemic and highland epidemic zones, 3.2% in 
the seasonal low transmission zone and zero in the low risk zone.
Conclusion: Malaria infection rates among febrile patients, with supporting data on age and pregnancy status pre-
senting to clinics in Kenya can provide invaluable epidemiological data on spatial heterogeneity of malaria and serve 
as replacements to more expensive community-based infection rates to plan and monitor malaria control.
© The Author(s) 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
The World Health Organization (WHO) recommends 
that all persons suspected of malaria should be examined 
for evidence of Plasmodium infection by either micros-
copy or rapid diagnostic tests (RDTs) before treatment is 
initiated [1]. RDTs for Plasmodium falciparum malaria 
are known to provide accurate diagnosis within a few 
minutes [2–5] and antimalarial treatment can be safely 
withheld if the result is negative [6]. Since the adoption of 
this global policy in 2010, the use of RDTs has doubled in 
Africa and increased the proportion of suspected malaria 
cases receiving a diagnostic test from 47 to 62% in 2013 
[7]. Kenya adopted the policy on universal parasitologi-
cal diagnosis on all cases suspected of malaria in 2010 [8] 
Open Access
Malaria Journal
*Correspondence:  sophiegithinji@gmail.com 
1 KEMRI-Wellcome Trust Collaborative Programme, Nairobi, Kenya
Full list of author information is available at the end of the article
Page 2 of 9Githinji et al. Malar J  (2016) 15:591 
and in 2012, the National Malaria Control Programme 
(NMCP) embarked on a plan of rolling out RDTs to 
strengthen the capacity of malaria diagnostic services 
across the country [9].
The use of fever test positivity rates (TPR) has a long 
history as a measure of malaria risk in communities, 
most notably those in areas where the ambition is malaria 
elimination [10, 11]. More recently, health facility-based 
surveys of malaria infection prevalence in febrile patients 
have been used as part of the rapid analysis of malaria 
risks in urban settings in Angola, [12] Mozambique [13], 
Burkina Faso, Benin, Tanzania and Côte d’Ivoire [14]. 
They have also been used as part of national surveys of 
malaria epidemiology in Niger [15] and The Gambia [16], 
and as a means to operationally measure intervention 
effectiveness through sentinel based case-control studies 
in Benin [17] and Madagascar [18].
Quality of malaria diagnosis and treatment studies have 
been undertaken in Kenya on a bi-annual basis since 2010 
[19–21]. These surveys have focused on describing rou-
tine clinical practices among febrile patients presenting 
to government out-patient departments and have high-
lighted that while the practice of parasitological diagno-
sis has increased significantly since 2010, testing rates for 
malaria have remained suboptimal. Over 30% of patients 
with fever were not tested with either an RDT or a blood 
slide in health facilities where diagnostics were available 
in September 2014, the month preceding the survey. This 
could be attributed to health worker clinical practices. 
Malaria case management trainings emphasizing on test-
ing before treatment and routine supervisory visits have 
been recommended to further improve adherence to the 
policy [20]. The present study aimed to characterize the 
TPR of malaria in patients with reported fever present-
ing to clinics across Kenya to define the patterns of febrile 
infection rates nationwide as a potential epidemiological 
surveillance tool, not possible from routine data or from 
standard quality of care surveys.
Methods
Study design and sampling
A national cross-sectional survey was undertaken at 
public health facilities sampled according to malaria 
endemicity zones. A stratified sampling frame was devel-
oped based upon the universe of 4242 geo-coded public 
health facilities offering out-patient general clinical ser-
vices [22, 23] within five malaria epidemiological zones. 
These zones have been used by the Ministry of Health 
for over 40  years [24, 25] and refined more recently to 
provide targeted malaria control services [22, 26, 27]. 
These malaria zones cover the high, stable perennial 
transmission areas of western Kenya around Lake Vic-
toria (lake endemic), moderate, seasonal transmission 
areas along the Kenyan coast (Coast endemic), acutely 
seasonal, low transmission areas of northern, eastern 
and southeastern Kenya (seasonal low transmission), the 
unstable, variable transmission areas of the highlands 
west of the Rift Valley (highland epidemic) and the cen-
tral highlands including areas around Nairobi tradition-
ally considered either free of malaria or of exceptionally 
low transmission (low risk).
The sample size was determined based on the propor-
tion of positive P. falciparum obtained during the RDT 
piloting period from 2007 to 2010, aggregated by ende-
micity zone. This proportion was used to compute the 
number of fever cases necessary to provide the estimated 
malaria case load per zone. A spatial sampling design tool 
was then used to draw a random spatially weighted sam-
ple proportionate to number and types of health facili-
ties within each zone (Fig. 1). With a target of at least 50 
febrile patients per facility [28], 234 public health facili-
ties were required across all zones.
Data collection
The survey was conducted in October and November 
2014, coinciding with the short rainy season. Seventy-
six senior laboratory technologists underwent a two day 
training workshop on survey procedures and a refresher 
course on how to diagnose malaria using Carestart HRP2 
P. falciparum RDT. Each survey technologist was based 
at a sampled facility for a maximum of 5 days to recruit 
all out-patients reporting any history of fever in the last 
48 h identified by clinicians who screened all presenting 
patients on the survey days. Patients with a history of 
fever in the last 48 h, who had not sought anti-malarial 
treatment before attending the facility were asked to 
provide informed consent. For each consenting partici-
pant, information was collected on basic demographics 
and usual residence. For women aged between 15 and 
49  years, additional information on pregnancy status 
was recorded. Each patient provided a single finger-prick 
blood sample for the malaria RDT. The RDT results were 
read as per the manufacturer’s instructions and recorded 
separately on the patient’s questionnaire. Test results 
were then passed on to the health care provider to use in 
managing the patient.
Data management and analysis
Data entry was undertaken in Access (Microsoft, USA) 
using customized data entry screens with inbuilt consist-
ency checks. Data analysis was performed using STATA, 
version 12 (StataCorp, College Station, Texas, USA). The 
primary outcome variable was prevalence of malaria cal-
culated as a percentage of the total number of people 
tested that had RDT positive results. Analysis was under-
taken overall and per malaria risk zone.
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Results
Sample description
The survey was conducted at all 234 sampled health facil-
ities, comprising of 23 hospitals, 99 health centres and 
112 dispensaries (Table 1). A total of 58,080 out-patients 
presented at the health facilities during the survey days 
and 12,913 (22.2%) reported a history of fever within the 
last 48 h. 10,557 consenting febrile out-patients without 
previous anti-malarial treatment were enrolled into the 
survey. Thirteen patients, all of them with negative RDT 
test results, were excluded from the analysis because of 
missing data on age. The background characteristics of 
the surveyed patients by malaria risk zone are shown in 
Table 1.
Prevalence of malaria by malaria zone and age
Overall, 1633 (15.5%) of the febrile patients surveyed 
were RDT positive for malaria at 124 (53.0%) facili-
ties. Among non-pregnant patients 1600 (15.8%) infec-
tions were detected among 10,112 patients with a recent 
Fig. 1 Location of sampled health facilities across five malaria endemicity zones in Kenya
Page 4 of 9Githinji et al. Malar J  (2016) 15:591 
history of fever. As would be expected, infection preva-
lence among non-pregnant patients varied between 
malaria risk zones, ranging from 0.6% in the Low risk 
zone to 41.6% in the high Lake endemic zone (Table 2). 
At 110 (47%) facilities, no patients were found to be 
RDT positive during the survey, of these 38 (34.5%) were 
located in the low risk zone, and the proportion of facili-
ties without any RDT positive febrile patients followed a 
similar pattern to the fraction of positive patients in each 
malaria zone (Table 2).
The age pattern of infection among non-pregnant 
patients across all malaria zones followed a similar pat-
tern, with low infection rates in febrile infants rising to 
the highest infection rates among febrile children aged 
5–9 and/or 10–14  years, then declining through young 
adulthood (Fig.  2). There were, however, important dif-
ferences in age positivity between malaria zones. The typ-
ical age-pattern of infection was much less pronounced 
in the very low risk zone, with risks of infection among 
fevers being similar across most age groups outside of 
infancy. Infants in the lake endemic zone had the highest 
rates of infection compared to all the other endemicity 
zones (Fig. 2). In the lake endemic zone, 6% of all infec-
tions were among children aged less than 1  year, com-
pared to 3% in the coast endemic and highland epidemic 
zone and less than 1% in the low risk zone and 0% in the 
exceptionally low risk zone (Table 2).
Malaria infection among febrile pregnant women
A total of 432 women with a recent history of fever 
reported being pregnant at the time of the consulta-
tion, of whom 33 (7.6%) were RDT positive. Sixteen of 
these infections were identified in the lake endemic zone 
among 51 pregnant women (prevalence 31.4%). Infection 
prevalence among febrile pregnant women was less than 
10% in the coast endemic and highland epidemic zone, 
3.2% in the seasonal low transmission zone and zero in 
the exceptionally low risk zone (Table 2).
Discussion
The present study was not designed to compare the 
direct congruence between fever test positivity rates 
(TPR) at health facilities and the prevalence of malaria 
infection among communities served by these facilities. 
Rather, a comparison is made between RDT positivity 
among all fevers presenting to facilities against the oper-
ational definitions of malaria zones used by the NMCP 
to define intervention options for control. The overall 
TPR (Table 2), and the age-patterns of TPR recorded at 
public health facilities (Fig.  2), varied between malaria 
endemic zones in ways which could be used to operation-
ally define malaria risk in communities and importantly 
how these age-specific metrics change between seasons, 
between years and overtime as interventions to prevent 
malaria exposure increase in coverage. The traditional 
high transmission areas around Lake Victoria showed 
the highest overall TPR, the highest rates of infection 
among febrile infants and the highest rates among febrile 
pregnant women (Table 2; Fig. 2). Areas that the Kenyan 
Ministry of Health regards as having intermediate trans-
mission along the Kenyan coast or in the epidemic prone 
areas of the highlands correspond to lower levels of over-
all TPR with fever infection rates less concentrated in the 
youngest children and intermediate levels of infection 
among febrile pregnant women (Table  2; Fig.  2). Areas 
where transmission has been historically very low are 


















 <5 606 794 634 471 534 3039
 5–14 525 581 524 461 410 2501
 ≥15 716 788 1055 1315 1130 5004
Male 774 956 928 929 787 4374
Female 1073 1207 1285 1318 1287 6170
Pregnant 51 77 70 126 108 432
Facility type
 Total facilities 37 47 50 54 46 234
 Hospital 5 5 3 5 5 23
 Health centre 12 11 22 27 27 99
 Dispensary 20 31 25 22 14 112
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characterized, as one might expect, with very low levels 
of infection among fevers presenting to clinic in all age 
groups or no infection reported in infants or pregnant 
women (Fig. 2).
These patterns of infection in fevers across the var-
ied epidemiology of Kenya are important because the 
default for classifications of malaria risk zones in Africa 
continues to be community-based malaria infection 
cross-sectional surveys [29]. Modelled and mapped com-
munity-based parasite prevalence is used for planning 
control across Africa [29–31] and to subsequently model 
presumed malaria burdens [7]. Surveys among asymp-
tomatic individuals at the community level are expen-
sive, even when constrained to simpler sampling frames 
such as school children [32]. Conversely, the testing of all 
fevers at health facilities should be routine [8] and in the-
ory these data should be available at no additional cost. 
Routine continuous data from facilities have the addi-
tional advantage of covering every month of every year, 
as opposed to single snap shot data from one off malaria 
indicator surveys. If data were available with enough col-
lateral information on age, pregnancy status and facili-
ties were geo-coded, such data would provide invaluable 
epidemiological evidence for programmes to compute 
spatial epidemiological risks to plan and monitor con-
trol operations and ultimately migrate into a surveillance 
system able to identify “hot spots” for targeted disease 
control [33] and be useful to exclude malaria risks (for 
example by examining infant or pregnancy fever infec-
tion risks, Table 2).
In The Gambia a more direct comparison of malaria 
infection rates among fevers at clinics and corresponding 
infection and serological rates at matched communities 
showed very similar age-patterns of risk and spatial het-
erogeneity [16]. A study of infection prevalence among 
fevers at clinics, similar to the study presented here, 
undertaken across Niger between 2009 and 2010, showed 
a congruence with the established bio-climatic zones and 
Table 2 RDT prevalence of infection among patients with reported fever in last 48 h at public health facilities in Kenya 
2014 – n/N (%) [95% confidence interval]
a Refers to the mean between health facilities in each zone





Meana 41.30% 21.90% 13.10% 3.80% 0.60% 14.70%
Median 46.00% 10.00% 2.00% 0.00% 0.00% 2.00%
IQR 31.0–56.0% 2.1–46.0% 0.0–19.0% 0.0–2.3% 0.0–0.0% 0.0–22.1%
Proportion of 
facilities without 
any RDT positive 
fevers
0/37 (0%) 10/47 (21.3%) 22/50 (44.0%) 40/54 (74.1%) 38/46 (82.6%) 110/234 (47.0%)
Percentage positive by age group








0/147 (0%) 59/684 (8.6%) 
[6.2–11.9]




















0/247 (0%) 411/1438 (28.6%) 
[23.5–34.3]















































0/108 (0%) 33/432 (7.6%) 
[5.1–11.4]
Percentage of positives aged








0 (0%) 59/1633 (3.6%) 
[2.7–4.8]
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Fig. 2 Age-specific test positivity rates among febrile patients attending out-patient clinics in October–November 2014 in five malaria endemicity 
zones
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seasonality used by the Niger National Malaria Control 
Programme to target malaria control [15]. Importantly, 
the Niger study highlighted the inadequacy of routine 
data from the health information system which included 
those suspected and not confirmed with malaria and the 
incomplete nature of data on how many individuals were 
tested for malaria [15].
There have been significant investments across Africa, 
including Kenya, to improve the ability of routine ser-
vices to accurately record health information in a timely 
fashion through the District Health Information System 
2.0 (DHIS2.0) or the Integrated Disease Surveillance 
Reporting System (IDSR) [34–36]. However, the detail, 
completeness and coverage of these data necessary to 
provide reliable epidemiological data for malaria pro-
grammes remains poor [37]. In Kenya, not all fevers are 
tested [20], the numbers of people tested is not always 
recorded, data are aggregated over districts, age groups, 
and time losing the granularity of information on age, 
seasonality, location and pregnancy status [38].
Interestingly, there was a high frequency of infection 
among children aged 10–14 years of age presenting with 
fever to clinics in all endemicity zones (Fig.  2). Recent 
studies across different settings have reported a grad-
ual shifting of peak parasite prevalence of malaria from 
younger to older children [39–41]. This has been attrib-
uted to enhanced control efforts that have resulted in 
children acquiring immunity to malaria more gradually 
than in the past and clinical attacks occurring in school-
age children more frequently [42]. This school-aged 
population are neglected from most child clinic services 
and community-based vector control programmes [42–
44], however they are an ever important source of clini-
cal malaria infections that should be highlighted during 
future clinical training programmes.
The default diagnostic test used in the present study 
was RDTs, these are far more ubiquitous than micros-
copy in Kenya [21] are available at all levels of the health 
sector and are subject to less between observer variability 
[2]. Patients who reported taking any anti-malarial treat-
ment in the 2 weeks preceding the survey were excluded 
from the study because of the well-known persistence 
of HRP2 antigenaemia after treatment [45]. How-
ever, a recent study in Uganda reported a much longer 
HRP2 persistence period extending to a median of 35 
to ≥42  days after treatment [46]. It is, therefore, possi-
ble that patients found positive in this survey, especially 
in the high endemic areas, may have been due to persis-
tent HRP2 antigenaemia. However, the associated risk 
of overtreatment of uninfected cases is considered more 
acceptable in malaria endemic zones than taking the risk 
of failing to detect cases. Recently, there has been reports 
of deletion of HRP2 gene which may lead to false RDT 
negative results [47, 48]. However, studies conducted in 
Africa showed HRP2 deletion in very small numbers of 
parasite isolates [49, 50], hence highly unlikely that the 
phenomenon may have influenced the results of this sur-
vey. The aim of the survey reported here was not to meas-
ure “true” prevalence of malaria in febrile populations, 
through expert microscopy or polymerase chain reac-
tion (PCR) assays, but emulate what might be routinely 
available if collected on all febrile patients. This study was 
limited in that it was restricted to only one time of the 
year and, therefore, not representative of periods of low 
transmission. Nor did the study examine the effects of 
residence and travel time to facilities that may indepen-
dently of age affect TPR [51]. A more detailed analysis 
of pockets of high transmission within broad ecological 
zones would have required larger facility sample sizes, 
beyond the scope of the present study. Pregnancy status 
was only asked about and no tests were done. This could 
have caused certain underreporting of malaria infec-
tion in pregnancy. Finally, it would have been interesting 
to examine a more direct spatial and temporal matched 
congruence between facility-based TPR and community-
based parasite prevalence across the country. Such stud-
ies would enable a calibration between two dominant 
measures used in malaria risk mapping and a more reli-
able pathway to estimating the relationships between 
combinations of TPR and community based prevalence 
with disease incidence [52–54].
Conclusions
Malaria infection rates among febrile patients present-
ing to clinics in Kenya could provide invaluable epide-
miological data on the seasonal, temporal and spatial 
heterogeneity of malaria and serve as replacements to 
more expensive community-based infection rates to plan 
and monitor malaria control. However, for these data to 
be of use for the national malaria control programme, 
increased testing rates, more granular information on 
patient level data and improved coverage of routine data 
are required.
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